Russo Gregg 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Catalyst (CPRX) Chief HR Officer Gregg Russo Receives 687 Shares
What Happened
Gregg Russo, Chief Human Resources Officer of Catalyst Pharmaceuticals (CPRX), had a tranche of restricted stock units vest on February 17, 2026. The vesting converted to 687 shares of common stock. To satisfy withholding taxes, 211 of those shares were withheld by the company, resulting in a net delivery of 476 shares to Russo. The filing shows no cash was paid by Russo for these shares (conversion/vesting rather than a market purchase).
Key Details
- Transaction date: 2026-02-17 (Form 4 filed 2026-02-19 — timely within the two-business-day window).
- Primary transactions reported:
- Code M (exercise/conversion of derivative): 687 shares acquired via RSU vesting.
- Code F (payment of tax liability): 211 shares withheld by the company to cover taxes (treated as disposition).
- Price/Value: No cash price reported for the conversion; one derivative entry shows $0 for a disposition of 687 shares (reflects conversion/delivery mechanics, not a sale).
- Net shares delivered to the insider: 476 shares (687 vested − 211 withheld).
- Shares owned after the transaction: Not stated in the provided filing details.
- Relevant footnotes from the filing:
- F1: Each RSU converts to one share upon vesting.
- F2: Shares were withheld to satisfy applicable withholding taxes.
- F3: RSUs vest in five equal annual tranches (1/5th each year beginning Feb 13, 2026).
- F4: Shares required to be delivered within 60 days of vesting; first tranche delivered Feb 17, 2026.
Context
This was a routine compensation vesting event (restricted stock units converting to common stock), not an open-market purchase or sale. Withholding shares for taxes is common and does not necessarily signal the insider’s view on the stock. Such awards increase the insider’s equity stake but also represent typical employee compensation and potential dilution to existing shareholders.
Insider Transaction Report
- Exercise/Conversion
Common Stock, par value $0.001 per share
[F1]2026-02-17+687→ 687 total - Tax Payment
Common Stock, par value $0.001 per share
[F2]2026-02-17−211→ 476 total - Exercise/Conversion
Restricted Stock Units
[F1][F3][F4]2026-02-17−687→ 71,786 total→ Common Stock (687 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
- [F2]Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock.
- [F3]Derivative securities vest in equal tranches, 1/5th each on February 13, 2026, February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030.
- [F4]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on February 17, 2026.